Categories: Government agency news release

8/20/2018

NIH brings balance to recap of study on blood test for gestational diabetes

1 2/22/2018

Potential harms and source of evidence missing in FDA summary of new blood test for concussion

2/15/2018

NIH recap on ‘brain disease test’: strong on study results, but lacks clarity on patient benefits

5/5/2017

Key detail missing in FDA approval of new acute myeloid leukemia drug: How much longer do people live?

4/4/2017

FDA could do a better job sharing numbers on costly new eczema drug

3/14/2017

FDA omits numbers on drug to reduce night-time visits to the bathroom; placebo was nearly as good

2/20/2017

FDA announces approval of new psoriasis drug with strong caveats on harms, but no data to support benefit claim

2/7/2017

NIH gives crisp summary of early stem cell transplants for multiple sclerosis, but missed some limitations

2 1/31/2017

How big is symptom improvement with new constipation drug? Readers might have to strain to find out

1/4/2017

Fenofibrate as add-on to statins for type 2 diabetes: NIH release promotes possible benefit found only in small subgroup of patients

News Release Reviews

Systematic, Criteria-Driven

@HealthNewsRevu

Retweet on Twitter HealthNewsReview.org Retweeted

Alan Cassels @AKECassels·

Puleeeeease... this 'game changer' weight loss drug causes more nausea and vomiting than a placebo. Some game, some change. My friend Gary would spank you for using the eighth word medical reporters should never, ever use. @garyschwitzer @thackerpd
https://www.healthnewsreview.org/toolkit/just-journalists-writing-tips-case-studies/7-words-and-more-you-shouldnt-use-in-medical-news/ https://twitter.com/OttawaCitizen/status/1361426796126830597

Reply on Twitter 1361431489326407680 Retweet on Twitter 13614314893264076806 Like on Twitter 13614314893264076808 Twitter 1361431489326407680

Retweet on Twitter HealthNewsReview.org Retweeted

RxISK @RxISK·

A scary @statnews Op-Ed warns that govt attempts to rein in Pharma may cut off access to "life-changing" drugs.

It takes @garyschwitzer to let us know: the author spent 10 years as Pfizer's public-policy chief. https://twitter.com/garyschwitzer/status/1360325022578053123

Reply on Twitter 1361420459284131843 Retweet on Twitter 13614204592841318439 Like on Twitter 136142045928413184318 Twitter 1361420459284131843

HealthNewsReview.org @HealthNewsRevu·

.@TranspariMED criticizes STAT op-ed for not disclosing pharma funding of author’s institute - similar to criticism we’ve made of STAT op-eds in the past. @transparify @ThinkTankWatch @icer_review https://www.healthnewsreview.org/2021/02/transparency-watchdog-criticizes-stats-non-disclosure-on-pro-pharma-op-ed/

Reply on Twitter 1360214949704982532 Retweet on Twitter 13602149497049825325 Like on Twitter 136021494970498253210 Twitter 1360214949704982532